Skip header and navigation

23 records – page 1 of 2.

Date Research Question / Title Unique ID Research Team
January 27, 2021 What is the risk of transmission of COVID-19 from high respiratory efforts for prolonged periods of time (>15 min) at a physical distance of 3-4 m or more? PH012501-02 ESR Public Health
January 26, 2021 What is the risk of transmission of COVID-19 from high respiratory efforts for prolonged periods of time (>15 min) at a physical distance of 3-4 m or more? PH012501-01 ESR Public Health
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR EOC
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR Table EOC
January 4, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2-01 ESR EOC
December 18, 2020 What is the risk of COVID-19 transmission during AGMP procedures? PPE120901 RR Personal Protective Equipment
December 17, 2020 How is COVID-19 transmitted from person-to-person and what is the most common source of transmission? INF121501 RR Infectious Disease
December 17, 2020 How is COVID-19 transmitted from person-to-person and what is the most common source of transmission? INF121501 RR Table Infectious Disease
December 15, 2020 How is COVID-19 transmitted from person-to-person and what is the most common source of transmission? INF121501-01 ESR Infectious Disease
December 11, 2020 What is the risk of COVID-19 transmission during AGMP procedures? PPE120901-01 ESR Personal Protective Equipment
September 8, 2020 What are the safety risks or disinfection concerns with the use of intubation boxes? EOC090202 RR EOC
September 2, 2020 What are the safety risks or disinfection concerns with the use of intubation boxes? EOC090202-01 ESR EOC
May 22, 2020 What is the relationship between antibody development and viral shedding and infectiousness? [Update] LAB041601v2-01 ESR Laboratory
May 19, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901 RR Epidemiology & Modelling
May 19, 2020 Risk estimates for clinical factors predicting severity and/ or mortality associated with COVID-19 EPM050901 RR Table Epidemiology & Modelling
May 19, 2020 What is the relationship between antibody development and viral shedding and infectiousness? [Update] LAB041601v2 RR Laboratory
May 12, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901-01 ESR Epidemiology & Modelling
May 8, 2020 What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update] LAB040701v2 RR Laboratory
May 8, 2020 What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update] LAB040701v2-01 ESR Laboratory
April 27, 2020 What is the period of communicability of symptomatic SARS-CoV-2? INF042401 RR Infectious Disease

23 records – page 1 of 2.